InvestorsHub Logo
Followers 398
Posts 28517
Boards Moderated 3
Alias Born 03/03/2004

Re: Pharma219 post# 19334

Thursday, 02/21/2013 12:38:37 AM

Thursday, February 21, 2013 12:38:37 AM

Post# of 66390
Pharma219, CERP has $22 million in Liabilities including over $16 million in Notes Payable and Convertible Notes;

http://www.sec.gov/Archives/edgar/data/1324759/000119312512470551/d438795d10q.htm

CERP has never made a profit while publicly traded. On $21 million+ in revenues in 2011 they lost over $16 million dollars. For the 1st 9 months of 2012 CERP reported a total of $786,000 in Gross Product Sales that cost $2,093,000 which sold at a loss of $1,323,000 before expenses.

The Reverse Split is to provide enough stock to cover obligations as required by the SEC. Simply raising the A/S to 2 Billion will not provide enough stock to do so.

Good luck.

I talk about stocks on iHub for free. No fee is worth preying on the gullible or the unaware.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HGYN News